跳至主要内容
临床试验/NCT05514405
NCT05514405招募中不适用

Effect of Remimazolam and Propofol on Postoperative Delirium in Elderly Patients Undergoing Hip and Knee Surgery

Inje University1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2022年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
82
试验地点
1
主要终点
Incidence of delirium 3 days after the end of operation

研究概览

简要总结

Remimazolam is an ultra-short acting benzodiazepine agonist which is used widely for general anesthesia and sedation. Remimazolam has several advantages. Remimazolam is rapidly metabolized by tissue esterase that it does not accumulate even after infusion for long periods of time. The presence of reversal agents (flumazenil) is also advantageous. Also, hemodynamic stability compared to propofol gives clinicians preference to use for geriatric anesthesia. However, the study on the effect of remimazolam compared to propofol on postoperative delirium have not been carried out. The purpose of the study is to compare the incidence of postoperative delirium and recovery profile in elderly patients undergoing orthopedic surgery using either remimazolam or propofol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 100 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • elderly patients undergoing hip or knee arthroplasty under general anesthesia.
  • body mass index >30 kg/m2

排除标准

  • moderate to severe liver dysfunction
  • moderate to severe renal dysfunction
  • unable to extubate in the operation room after operation
  • benzodiazepine dependence
  • sensitivity to anesthetic drugs used for study (Benzodiazepines, Propofol, Remifentanil, Fentanyl citrate, Rocuronium bromide, Sugammadex, Flumazenil)
  • acute angle glaucoma
  • received (benzodiazepine, antianxiety drugs, antidepressant, antipsychotic drugs) within 24 hours.
  • acute psychotic depression
  • history stroke or cerebrovascular disease

研究组 & 干预措施

Remimazolam group

Experimental

Remimazolam is started during induction of anesthesia at the rate of 6 mg/kg/hr and continued at the rate of 1 mg/kg/hr (within 0.3-2 mg/kg/hr). Remimazolam is stopped 20 minutes before end of operation.

干预措施: Remimazolam (Byfavo) (Drug)

Propofol group

Active Comparator

Propofol is continuously infused within 1-5 μg/mL.

干预措施: Propofol (Drug)

结局指标

主要结局

Incidence of delirium 3 days after the end of operation

时间窗: Upto 3 days after surgery

delirium is evaluated preoperatively and 3 days after surgery using Mini-Mental State Examination

次要结局

  • quality of recovery (QoR-15) 3 days after the end of the operation(Upto 3 days after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

In-Jung Jun

assisstant professor

Inje University

研究点 (1)

Loading locations...

相似试验